• About
  • Events
  • Offices
  • Careers
  • Students
  • Media
Background Image
Bennett Jones
  • People
  • Services
  • Experience
  • Insights
Search By:
 
Find a Person
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z all
People
Services
Experience
Insights
Offices
About
Media
Search
Aboriginal Law
Accountant Liability Litigation
Agribusiness, Food & Beverage
Anti-Spam Law
Appellate Advocacy & Judicial Review
Arbitration
Asset/Equipment Finance & Leasing
Aviation
Banks & Financial Institutions
Bermuda & Caribbean
Biotech, Pharma & Lifesciences
Cannabis Law
China
Class Action Litigation
Climate Change
Commercial Litigation
Commercial Real Estate
Commercial Transactions
Competition/Antitrust
Constitutional Law
Construction
Corporate Finance
Corporate Governance
Cybersecurity
Defamation
Defence & Security
Employment Services
Energy
Energy Litigation
Environmental Law
Estate Litigation
Financial Services
Fintech & Blockchain
Forestry
Franchising
Fraud Law
Gaming & Hospitality
Governmental Affairs & Public Policy
Health Law
India
Infrastructure & Project Development
Intellectual Property Law
Intellectual Property Litigation
International Arbitration
International Trade & Investment
IT & Business Services
Mergers & Acquisitions
Middle East & North Africa
Mining
Oil & Gas
Payment Solutions
Pensions & Benefits
Power & Renewables
Privacy & Data Protection
Private Equity & Capital Funds
Procurement & Outsourcing
Product Liability
Product Regulation
Project Finance
Property Development & Real Estate
Regulatory
Restructuring & Insolvency
Retail
Securities Litigation
Shareholder Activism & Critical Situations
Structured Finance & Asset Securitization
Tax
Tax Litigation & Dispute Resolution
Technology Law
Technology, Media & Entertainment
Trading & Derivatives
Transfer Pricing
Transportation
United States of America
Venture Capital
Wills, Estates & Trusts
 

Emerald Health Sciences in Secondary Offering of Shares of Emerald Health Therapeutics

Contact Us
 
Subscribe
Print
Share
Share
Twitter
LinkedIn
Email

Mandate Details

     
Date Announced: January 15, 2019
Date Closed: January 17, 2019
Deal Value: $7 million
Client Name: Emerald Health Sciences Inc. and Emerald Health Therapeutics, Inc.
Bennett Jones acted for both Emerald Health Sciences and Emerald Health Therapeutics, Inc. in the secondary offering by EHS of 2.8 million shares of EHT to a single institutional investor at a price of $2.50 per Secondary Share for gross proceeds of $7 million. To facilitate the Secondary Offering, EHT filed a prospectus supplement in all of the provinces of Canada, except Quebec.
Subscribe
Share
Share      
 
Twitter
LinkedIn
Email
 

Key Contacts

  • James D. Beeby James D. Beeby, Partner
  • Lisa  Kakoske Lisa Kakoske, Associate
  • Tajinder  Rathor Tajinder Rathor, Associate

Related Links

  • Experience

Related Expertise

  • Cannabis Law
  • Corporate Finance

Firm Information

  • People
  • About
  • Recruitment
  • Anti-Spam Learning Centre
  • Kickstart
  • Client Extranet

Offices

  • Calgary
  • Edmonton
  • Ottawa
  • Toronto
  • Vancouver
  • New York
  • United States of America
  • Beijing
  • Doha

Stay Connected

Careers

  • Privacy Policy
  • Disclaimer
  • Terms of Use

© Bennett Jones LLP 2019 All rights reserved. Bennett Jones refers collectively to the Canadian legal practice of Bennett Jones LLP and the international legal practices and consulting activities of various entities which are associated with Bennett Jones LLP

Bennett Jones